H47-33360-09661
4 vaccinations
1 coded response
34 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 992 / WA
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Moderna
- 2021-01-23
-
2021-01-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2021-01-26
- 2021-01-27
- 2021-01-29
- 2021-01-30
- 2021-02-06
- 2021-02-13
-
2021-02-16
Dose 2 — Moderna
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-05-18
- 2021-08-17
-
2021-12-06
Dose 3 — Moderna
-
2022-02-16
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Dose 4 — Pfizer-BioNTechCo-administered: Flu:Tetanus
-
2022-10-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-03
-
2022-10-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-05
- 2022-10-09
- 2022-10-14
- 2022-10-23
- 2022-10-28
- 2022-11-06
- 2022-11-11
- 2022-12-30
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Moderna | |
| 2 | 2021-02-16 | Moderna | |
| 3 | 2021-12-06 | Moderna | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | Flu:Tetanus |
Free text
Release 11 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release